Cargando…
Promoter DNA Methylation Frequency and Clinicopathological Role of miR-129-2 Gene in Patients with Chronic Lymphocytic Leukemia
OBJECTIVES: Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of apparently mature B-type lymphocytes in the lymphohematopoietic organs. Methylation in promoters of tumor suppressor genes is one of the mechanisms that causes blood malignancy. In this study, we evaluated the pro...
Autores principales: | Hashemi, Morteza, Mohammadipour, Mahshid, Rostami, Shahrbano, Soltanpour, Mohammad Soleiman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OMJ
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383833/ https://www.ncbi.nlm.nih.gov/pubmed/32724662 http://dx.doi.org/10.5001/omj.2020.71 |
Ejemplares similares
-
Expression of miR-129-5p and miR-433 in the serum of breast cancer patients and their relationship with clinicopathological features
por: Xue, Jinhui, et al.
Publicado: (2020) -
Evaluation of the expressed miR-129 and miR-549a in patients with multiple sclerosis
por: Montazeri, Mina, et al.
Publicado: (2021) -
Association of hsa-miR-5571-5p Expression with Clinicopathological Factors besides Identification of Its Hub Target Genes and Key Pathway in Breast Cancer
por: Samie Ghahfarokhi, Mahshid, et al.
Publicado: (2023) -
MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
por: Torres-Ferreira, Jorge, et al.
Publicado: (2017) -
Aberrant Methylation of APAF-1 Gene in Acute Myeloid Leukemia Patients
por: Rostami, Shahrbano, et al.
Publicado: (2017)